Pages that link to "Q28086960"
Jump to navigation
Jump to search
The following pages link to β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies (Q28086960):
Displayed 34 items.
- Genomic approaches to identifying targets for treating β hemoglobinopathies (Q26799214) (← links)
- The European Hematology Association Roadmap for European Hematology Research: a consensus document (Q28830861) (← links)
- Targeting iron metabolism in drug discovery and delivery (Q33757232) (← links)
- HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics (Q36138738) (← links)
- Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera (Q37097115) (← links)
- Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016. (Q37429238) (← links)
- β-Thalassemia Patients Revealed a Significant Change of Untargeted Metabolites in Comparison to Healthy Individuals. (Q37638068) (← links)
- Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia (Q37692645) (← links)
- A complicated disease: what can be done to manage thalassemia major more effectively? (Q38607875) (← links)
- Ineffective erythropoiesis and regulation of iron status in iron loading anaemias (Q38613789) (← links)
- Thalassemia 2016: Modern medicine battles an ancient disease (Q38625435) (← links)
- Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development (Q38988198) (← links)
- A Red Carpet for Iron Metabolism. (Q39106718) (← links)
- Investigational drugs in phase I and phase II clinical trials for thalassemia. (Q39328286) (← links)
- Molecular Characterization of β-Thalassemia in the Czech and Slovak Populations: Mediterranean, Asian and Unique Mutations (Q40865017) (← links)
- Resolutions for the New Year (Q42722329) (← links)
- Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia (Q43109013) (← links)
- New therapeutic targets in transfusion-dependent and -independent thalassemia. (Q45875628) (← links)
- Skin Disorders in Egyptian Children with β-Thalassemia Major (Q47371612) (← links)
- What can we learn from ineffective erythropoiesis in thalassemia? (Q47885433) (← links)
- Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model. (Q48228826) (← links)
- β-Thalassemia intermedia: a comprehensive overview and novel approaches (Q49588086) (← links)
- Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in no (Q50025029) (← links)
- Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea. (Q50897207) (← links)
- Hepcidin agonists as therapeutic tools. (Q52663760) (← links)
- Depression, Anxiety, and Perceived Social Support among Adults with Beta-Thalassemia Major: Cross-Sectional Study. (Q55082196) (← links)
- Iron metabolism under conditions of ineffective erythropoiesis in beta-thalassemia (Q58605168) (← links)
- Relationship between liver iron concentration determined by R2-MRI, serum ferritin, and liver enzymes in patients with thalassemia intermedia (Q60301528) (← links)
- Reflection of treatment proficiency of hydroxyurea treated β-thalassemia serum samples through nuclear magnetic resonance based metabonomics (Q61796055) (← links)
- The Pleiotropic Effects of GATA1 and KLF1 in Physiological Erythropoiesis and in Dyserythropoietic Disorders (Q64252935) (← links)
- Thalassaemia (Q88678149) (← links)
- Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult beta-thalassemia major (Q90466673) (← links)
- Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia (Q90589788) (← links)
- Controversies on the Consequences of Iron Overload and Chelation in MDS (Q97545523) (← links)